RecruitingEarly Phase 1NCT06326996

Thiamine Intervention and Coronary Artery Bypass Grafting

Thiamine Intervention and Cognition in Older Adults Undergoing Coronary Artery Bypass Grafting - A Randomized Clinical Trial.

Sponsor

University of California, Los Angeles

Enrollment

52 participants

Start Date

Oct 10, 2024

Study Type

INTERVENTIONAL

Conditions

Coronary Heart Disease Coronary Artery Bypass Grafting

Summary

The purpose of this study is to gain a better understanding of the association between brain changes and cognitive deficits in coronary heart disease (CHD) patients undergoing coronary artery bypass grafting (CABG) and whether a low-cost thiamine intervention can be used to reduce post-CABG cognitive issues in CHD subjects.

Eligibility

Min Age: 60 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo and a drug called Thiamine for people with coronary artery bypass grafting and coronary heart disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 60 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.